Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients
Open Access
- 1 April 1990
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 116 (4), 640-647
- https://doi.org/10.1016/s0022-3476(05)81619-1
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infectionThe Journal of Pediatrics, 1989
- Zidoyudine-Induced HepatotoxicityAnnals of Internal Medicine, 1989
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- Possible Zidovudine-lnduced HepatotoxicityPublished by American Medical Association (AMA) ,1987
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983